Crohn's disease

G Roda, S Chien Ng, PG Kotze, M Argollo… - Nature Reviews …, 2020 - nature.com
Crohn's disease is an inflammatory bowel disease that is characterized by chronic
inflammation of any part of the gastrointestinal tract, has a progressive and destructive …

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

ECCO guidelines on therapeutics in ulcerative colitis: medical treatment

T Raine, S Bonovas, J Burisch… - Journal of Crohn's …, 2022 - academic.oup.com
Ulcerative colitis [UC] is a chronic inflammatory bowel disease [IBD] characterised by colonic
inflammation extending to a variable extent from the rectum. Care of the patient with UC …

ACG clinical guideline: ulcerative colitis in adults

DT Rubin, AN Ananthakrishnan… - Official journal of the …, 2019 - journals.lww.com
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

A comprehensive review and update on ulcerative colitis

M Gajendran, P Loganathan, G Jimenez, AP Catinella… - Disease-a-month, 2019 - Elsevier
Ulcerative colitis (UC) is a chronic idiopathic inflammatory bowel disorder of the colon that
causes continuous mucosal inflammation extending from the rectum to the more proximal …

[HTML][HTML] Multi-omics reveal microbial determinants impacting responses to biologic therapies in inflammatory bowel disease

JWJ Lee, D Plichta, L Hogstrom, NZ Borren, H Lau… - Cell host & …, 2021 - cell.com
The intestinal microbiome is a key determinant of responses to biologic therapy in
inflammatory bowel disease (IBD). However, diverse therapeutics and variable responses …

Evidence-based clinical practice guidelines for inflammatory bowel disease

K Matsuoka, T Kobayashi, F Ueno, T Matsui… - Journal of …, 2018 - Springer
Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract,
but possibly other gastrointestinal and extraintestinal organs. Although etiology is still …

CD4 T-cell subsets and the pathophysiology of inflammatory bowel disease

R Gomez-Bris, A Saez, B Herrero-Fernandez… - International journal of …, 2023 - mdpi.com
Inflammatory bowel disease (IBD) is an umbrella term for the chronic immune-mediated
idiopathic inflammation of the gastrointestinal tract, manifesting as Crohn's disease (CD) or …

Prevalence of anxiety and depression in patients with inflammatory bowel disease

G Byrne, G Rosenfeld, Y Leung, H Qian… - Canadian Journal of …, 2017 - Wiley Online Library
Background. Inflammatory bowel disease (IBD) patients are not routinely screened for
depression and anxiety despite knowledge of an increased prevalence in people with …

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study

H Abu-Sbeih, FS Ali, D Alsaadi, J Jennings… - … for immunotherapy of …, 2018 - Springer
Background Immune-mediated diarrhea and colitis (IMDC) can limit immune checkpoint
inhibitors (ICIs) treatment, which is efficacious for advanced malignancies. Steroids and …